There are a number of new treatments on the horizon. They are somewhat farther a field, but there are, there's a drug that talks to the chemical that signals those bone eating cells, the ...

a deployment of a large number of new measures will be essential in the future. Numerous efforts should be made in order to promote the diagnosis, prevention and treatment of osteoporosis ...

Thousands of women crippled by osteoporosis could benefit from the first drug to rebuild their bones ... This results in the formation of new bone, increased bone density and improved resistance ...

Researchers at Hospital for Special Surgery (HSS) have pinpointed a cellular target that could enhance the way osteoporosis ...

Amgen and UCB have been trumpeting new data from their romosozumab osteoporosis drug – but although the phase 3 FRAME trial met targets of reducing vertebral fractures, it did not seem to ...

Women 50 to 60 who got two IV infusions of zoledronate (Reclast) within five years had a 44% lower risk of spinal fractures, ...

"This study also revealed a new target for managing bone health in metabolic bone and many orthopedic disorders." Osteoporosis ... we can recommend treatment options to promote healthy bones.

Alison Smith, who was diagnosed with osteoporosis in 2011, told BBC R4's Today programme the new treatment would make a "big difference" to many patients who are "reluctant" to take medication ...

"The ESCEO international working group was convened to provide new management recommendations ... addressing the efficacy of ...

Figure 1 shows annual osteoporosis prevalence and treatment estimates from MEPS years 1999 to 2005 among the sample of patients ages 50 years and older who self-reported osteoporosis. Self-report ...

New Zealand’s medicine-funding agency Pharmac is widening access to a medicine called denosumab for people with osteoporosis.

“The term osteoporosis screening refers to use of bone density, x-ray studies or other tools to identify persons at an increased risk of fractures or bone breaks,” Dr. Thomas Weber, an endocrinologist ...